Equol (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Equol" in French language version.

refsWebsite
Global rank French rank
2nd place
3rd place
4th place
12th place
57th place
4th place
6,663rd place
5,973rd place
1,389th place
508th place
222nd place
129th place

aspetjournals.org

dmd.aspetjournals.org

  • (en) Corinna E. Rüfer, Hansruedi Glatt et Sabine E. Kulling, « Structural Elucidation Of Hydroxylated Metabolites Of The Isoflavan Equol By Gas Chromatography-Mass Spectrometry And High-Performance Liquid Chromatography-Mass Spectrometry », Drug Metabolism and Disposition, vol. 34, no 1,‎ , p. 51–60 (ISSN 0090-9556 et 1521-009X, DOI 10.1124/dmd.105.004929, lire en ligne [PDF], consulté le )

doi.org

dx.doi.org

  • (en) Corinna E. Rüfer, Hansruedi Glatt et Sabine E. Kulling, « Structural Elucidation Of Hydroxylated Metabolites Of The Isoflavan Equol By Gas Chromatography-Mass Spectrometry And High-Performance Liquid Chromatography-Mass Spectrometry », Drug Metabolism and Disposition, vol. 34, no 1,‎ , p. 51–60 (ISSN 0090-9556 et 1521-009X, DOI 10.1124/dmd.105.004929, lire en ligne [PDF], consulté le )
  • « Enantioselective synthesis of S-equol from dihydrodaidzein by a newly isolated anaerobic human intestinal bacterium », Appl. Environ. Microbiol., vol. 71, no 1,‎ , p. 214–9 (PMID 15640190, PMCID 544246, DOI 10.1128/AEM.71.1.214-219.2005)
  • Muthyala, Ju, Sheng et Williams, « Equol, a natural estrogenic metabolite from soy isoflavones », Bioorganic & Medicinal Chemistry, vol. 12, no 6,‎ , p. 1559–1567 (ISSN 0968-0896, PMID 15018930, DOI 10.1016/j.bmc.2003.11.035)
  • « High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart », Br. J. Nutr., vol. 94, no 6,‎ , p. 873–6 (PMID 16351761, DOI 10.1079/bjn20051565)
  • Marrian et Haslewood, GA, « Equol, a new inactive phenol isolated from the ketohydroxyoestrin fraction of mares' urine », The Biochemical Journal, vol. 26, no 4,‎ , p. 1227–32 (PMID 16744928, PMCID 1261026, DOI 10.1042/bj0261227)
  • Setchell et Clerici, C, « Equol: history, chemistry, and formation », The Journal of Nutrition, vol. 140, no 7,‎ , p. 1355S–62S (PMID 20519412, PMCID 2884333, DOI 10.3945/jn.109.119776)
  • Axelson, Kirk, DN, Farrant, RD et Cooley, G, « The identification of the weak oestrogen equol [7-hydroxy-3-(4'-hydroxyphenyl)chroman] in human urine », The Biochemical Journal, vol. 201, no 2,‎ , p. 353–7 (PMID 7082293, PMCID 1163650, DOI 10.1042/bj2010353)
  • Setchell, Borriello, SP, Hulme, P et Kirk, DN, « Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease », The American Journal of Clinical Nutrition, vol. 40, no 3,‎ , p. 569–78 (PMID 6383008, DOI 10.1093/ajcn/40.3.569)
  • Setchell, Brown, NM et Lydeking-Olsen, E, « The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones », The Journal of Nutrition, vol. 132, no 12,‎ , p. 3577–84 (PMID 12468591, DOI 10.1093/jn/132.12.3577)
  • Atkinson, Frankenfeld, CL et Lampe, JW, « Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health », Experimental Biology and Medicine (Maywood, N.J.), vol. 230, no 3,‎ , p. 155–70 (PMID 15734719, DOI 10.1177/153537020523000302)
  • « Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor {α} (ER{α}) and ERβ in human cells », Toxicol. Sci., vol. 80, no 1,‎ , p. 14–25 (PMID 15084758, DOI 10.1093/toxsci/kfh147, lire en ligne)
  • Setchell, Clerici, C, Lephart, ED et Cole, SJ, « S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora », The American Journal of Clinical Nutrition, vol. 81, no 5,‎ , p. 1072–9 (PMID 15883431, DOI 10.1093/ajcn/81.5.1072)
  • Prossnitz et Barton, « Estrogen biology: New insights into GPER function and clinical opportunities », Molecular and Cellular Endocrinology, vol. 389, nos 1–2,‎ , p. 71–83 (ISSN 0303-7207, PMID 24530924, PMCID 4040308, DOI 10.1016/j.mce.2014.02.002)
  • Setchell, Zhao, X, Jha, P et Heubi, JE, « The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers », The American Journal of Clinical Nutrition, vol. 90, no 4,‎ , p. 1029–37 (PMID 19710188, PMCID 2744624, DOI 10.3945/ajcn.2009.27981)
  • Setchell, Zhao, X, Shoaf, SE et Ragland, K, « The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women », The Journal of Nutrition, vol. 139, no 11,‎ , p. 2037–43 (PMID 19776178, DOI 10.3945/jn.109.110874)
  • Setchell et Clerici, C, « Equol: pharmacokinetics and biological actions », The Journal of Nutrition, vol. 140, no 7,‎ , p. 1363S–8S (PMID 20519411, PMCID 2884334, DOI 10.3945/jn.109.119784)
  • Lampe, Karr, SC, Hutchins, AM et Slavin, JL, « Urinary equol excretion with a soy challenge: influence of habitual diet », Proceedings of the Society for Experimental Biology and Medicine, vol. 217, no 3,‎ , p. 335–9 (PMID 9492344, DOI 10.3181/00379727-217-44241)
  • Setchell et Cole, SJ, « Method of defining equol-producer status and its frequency among vegetarians », The Journal of Nutrition, vol. 136, no 8,‎ , p. 2188–93 (PMID 16857839, DOI 10.1093/jn/136.8.2188)
  • Rowland, Wiseman, H, Sanders, TA et Adlercreutz, H, « Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora », Nutrition and Cancer, vol. 36, no 1,‎ , p. 27–32 (PMID 10798213, DOI 10.1207/S15327914NC3601_5)
  • Watanabe, Yamaguchi, M, Sobue, T et Takahashi, T, « Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako) », The Journal of Nutrition, vol. 128, no 10,‎ , p. 1710–5 (PMID 9772140, DOI 10.1093/jn/128.10.1710)
  • Arai, Uehara, M, Sato, Y et Kimira, M, « Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake », Journal of Epidemiology, vol. 10, no 2,‎ , p. 127–35 (PMID 10778038, DOI 10.2188/jea.10.127)
  • Akaza, Miyanaga, N, Takashima, N et Naito, S, « Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents », Japanese Journal of Clinical Oncology, vol. 34, no 2,‎ , p. 86–9 (PMID 15067102, DOI 10.1093/jjco/hyh015)
  • Song, Atkinson, C, Frankenfeld, CL et Jokela, T, « Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls », The Journal of Nutrition, vol. 136, no 5,‎ , p. 1347–51 (PMID 16614428, DOI 10.1093/jn/136.5.1347)
  • Patisaul et Jefferson, « The pros and cons of phytoestrogens. », Front Neuroendocrinol, vol. 31, no 4,‎ , p. 400–419 (PMID 20347861, PMCID 3074428, DOI 10.1016/j.yfrne.2010.03.003)
  • Teas et Hurley, TG, « Dietary seaweed modifies estrogen and phytoestrogen metabolism in healthy postmenopausal women », The Journal of Nutrition, vol. 139, no 9,‎ , p. 939–44 (PMID 19321575, DOI 10.3945/jn.108.100834)
  • « S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora », Am. J. Clin. Nutr., vol. 81, no 5,‎ , p. 1072–9 (PMID 15883431, DOI 10.1093/ajcn/81.5.1072)
  • Setchell et Clerici, « Equol: History, Chemistry, and Formation », The Journal of Nutrition, vol. 140, no 7,‎ , p. 1355S–1362S (PMID 20519412, PMCID 2884333, DOI 10.3945/jn.109.119776)
  • Lephart, « Protective effects of equol and their polyphenolic isomers against dermal aging: Microarray/protein evidence with clinical implications and unique delivery into human skin », Pharmaceutical Biology, vol. 51, no 11,‎ , p. 1393–1400 (ISSN 1388-0209, PMID 23862588, DOI 10.3109/13880209.2013.793720)
  • « Skin aging and oxidative stress: Equol's anti-aging effects via biochemical and molecular mechanisms », Ageing Research Reviews, vol. 31,‎ , p. 36–54 (PMID 27521253, DOI 10.1016/j.arr.2016.08.001)
  • Magnet, Urbanek, Gaisberger et Tomeva, « Topical equol preparation improves structural and molecular skin parameters », International Journal of Cosmetic Science, vol. 39, no 5,‎ , p. 535–542 (PMID 28574180, DOI 10.1111/ics.12408)
  • (en) Vivienne E. Reeve, Sitarina Widyarini, Diane Domanski et Elaine Chew, « Protection Against Photoaging in the Hairless Mouse by the Isoflavone Equol », Photochemistry and Photobiology, vol. 81, no 6,‎ , p. 1548–1553 (ISSN 0031-8655 et 1751-1097, DOI 10.1562/2005-07-26-RA-624, lire en ligne, consulté le )
  • Lephart, « Equol's Anti-Aging Effects Protect against Environmental Assaults by Increasing Skin Antioxidant Defense and ECM Proteins While Decreasing Oxidative Stress and Inflammation », Cosmetics, vol. 5, no 1,‎ , p. 16 (ISSN 2079-9284, DOI 10.3390/cosmetics5010016)
  • (de) Mayr, Georgiev et Toulev, « Eine Proof-of-concept-Studie von Isoflavandiol-E55-RS-Vaginalkapseln oder Vaginalgel zur Linderung der menopausalen Vaginalatrophie », Journal für Gynäkologische Endokrinologie/Österreich, vol. 29, no 1,‎ , p. 13–22 (ISSN 1996-1553, DOI 10.1007/s41974-019-0085-9)

issn.org

portal.issn.org

  • (en) Corinna E. Rüfer, Hansruedi Glatt et Sabine E. Kulling, « Structural Elucidation Of Hydroxylated Metabolites Of The Isoflavan Equol By Gas Chromatography-Mass Spectrometry And High-Performance Liquid Chromatography-Mass Spectrometry », Drug Metabolism and Disposition, vol. 34, no 1,‎ , p. 51–60 (ISSN 0090-9556 et 1521-009X, DOI 10.1124/dmd.105.004929, lire en ligne [PDF], consulté le )
  • Muthyala, Ju, Sheng et Williams, « Equol, a natural estrogenic metabolite from soy isoflavones », Bioorganic & Medicinal Chemistry, vol. 12, no 6,‎ , p. 1559–1567 (ISSN 0968-0896, PMID 15018930, DOI 10.1016/j.bmc.2003.11.035)
  • Prossnitz et Barton, « Estrogen biology: New insights into GPER function and clinical opportunities », Molecular and Cellular Endocrinology, vol. 389, nos 1–2,‎ , p. 71–83 (ISSN 0303-7207, PMID 24530924, PMCID 4040308, DOI 10.1016/j.mce.2014.02.002)
  • Lephart, « Protective effects of equol and their polyphenolic isomers against dermal aging: Microarray/protein evidence with clinical implications and unique delivery into human skin », Pharmaceutical Biology, vol. 51, no 11,‎ , p. 1393–1400 (ISSN 1388-0209, PMID 23862588, DOI 10.3109/13880209.2013.793720)
  • (en) Vivienne E. Reeve, Sitarina Widyarini, Diane Domanski et Elaine Chew, « Protection Against Photoaging in the Hairless Mouse by the Isoflavone Equol », Photochemistry and Photobiology, vol. 81, no 6,‎ , p. 1548–1553 (ISSN 0031-8655 et 1751-1097, DOI 10.1562/2005-07-26-RA-624, lire en ligne, consulté le )
  • Lephart, « Equol's Anti-Aging Effects Protect against Environmental Assaults by Increasing Skin Antioxidant Defense and ECM Proteins While Decreasing Oxidative Stress and Inflammation », Cosmetics, vol. 5, no 1,‎ , p. 16 (ISSN 2079-9284, DOI 10.3390/cosmetics5010016)
  • (de) Mayr, Georgiev et Toulev, « Eine Proof-of-concept-Studie von Isoflavandiol-E55-RS-Vaginalkapseln oder Vaginalgel zur Linderung der menopausalen Vaginalatrophie », Journal für Gynäkologische Endokrinologie/Österreich, vol. 29, no 1,‎ , p. 13–22 (ISSN 1996-1553, DOI 10.1007/s41974-019-0085-9)

nih.gov

ncbi.nlm.nih.gov

  • « Enantioselective synthesis of S-equol from dihydrodaidzein by a newly isolated anaerobic human intestinal bacterium », Appl. Environ. Microbiol., vol. 71, no 1,‎ , p. 214–9 (PMID 15640190, PMCID 544246, DOI 10.1128/AEM.71.1.214-219.2005)
  • Muthyala, Ju, Sheng et Williams, « Equol, a natural estrogenic metabolite from soy isoflavones », Bioorganic & Medicinal Chemistry, vol. 12, no 6,‎ , p. 1559–1567 (ISSN 0968-0896, PMID 15018930, DOI 10.1016/j.bmc.2003.11.035)
  • « High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart », Br. J. Nutr., vol. 94, no 6,‎ , p. 873–6 (PMID 16351761, DOI 10.1079/bjn20051565)
  • Marrian et Haslewood, GA, « Equol, a new inactive phenol isolated from the ketohydroxyoestrin fraction of mares' urine », The Biochemical Journal, vol. 26, no 4,‎ , p. 1227–32 (PMID 16744928, PMCID 1261026, DOI 10.1042/bj0261227)
  • Setchell et Clerici, C, « Equol: history, chemistry, and formation », The Journal of Nutrition, vol. 140, no 7,‎ , p. 1355S–62S (PMID 20519412, PMCID 2884333, DOI 10.3945/jn.109.119776)
  • Axelson, Kirk, DN, Farrant, RD et Cooley, G, « The identification of the weak oestrogen equol [7-hydroxy-3-(4'-hydroxyphenyl)chroman] in human urine », The Biochemical Journal, vol. 201, no 2,‎ , p. 353–7 (PMID 7082293, PMCID 1163650, DOI 10.1042/bj2010353)
  • Setchell, Borriello, SP, Hulme, P et Kirk, DN, « Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease », The American Journal of Clinical Nutrition, vol. 40, no 3,‎ , p. 569–78 (PMID 6383008, DOI 10.1093/ajcn/40.3.569)
  • Setchell, Brown, NM et Lydeking-Olsen, E, « The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones », The Journal of Nutrition, vol. 132, no 12,‎ , p. 3577–84 (PMID 12468591, DOI 10.1093/jn/132.12.3577)
  • Atkinson, Frankenfeld, CL et Lampe, JW, « Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health », Experimental Biology and Medicine (Maywood, N.J.), vol. 230, no 3,‎ , p. 155–70 (PMID 15734719, DOI 10.1177/153537020523000302)
  • « Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor {α} (ER{α}) and ERβ in human cells », Toxicol. Sci., vol. 80, no 1,‎ , p. 14–25 (PMID 15084758, DOI 10.1093/toxsci/kfh147, lire en ligne)
  • Setchell, Clerici, C, Lephart, ED et Cole, SJ, « S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora », The American Journal of Clinical Nutrition, vol. 81, no 5,‎ , p. 1072–9 (PMID 15883431, DOI 10.1093/ajcn/81.5.1072)
  • Prossnitz et Barton, « Estrogen biology: New insights into GPER function and clinical opportunities », Molecular and Cellular Endocrinology, vol. 389, nos 1–2,‎ , p. 71–83 (ISSN 0303-7207, PMID 24530924, PMCID 4040308, DOI 10.1016/j.mce.2014.02.002)
  • Setchell, Zhao, X, Jha, P et Heubi, JE, « The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers », The American Journal of Clinical Nutrition, vol. 90, no 4,‎ , p. 1029–37 (PMID 19710188, PMCID 2744624, DOI 10.3945/ajcn.2009.27981)
  • Setchell, Zhao, X, Shoaf, SE et Ragland, K, « The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women », The Journal of Nutrition, vol. 139, no 11,‎ , p. 2037–43 (PMID 19776178, DOI 10.3945/jn.109.110874)
  • Setchell et Clerici, C, « Equol: pharmacokinetics and biological actions », The Journal of Nutrition, vol. 140, no 7,‎ , p. 1363S–8S (PMID 20519411, PMCID 2884334, DOI 10.3945/jn.109.119784)
  • Lampe, Karr, SC, Hutchins, AM et Slavin, JL, « Urinary equol excretion with a soy challenge: influence of habitual diet », Proceedings of the Society for Experimental Biology and Medicine, vol. 217, no 3,‎ , p. 335–9 (PMID 9492344, DOI 10.3181/00379727-217-44241)
  • Setchell et Cole, SJ, « Method of defining equol-producer status and its frequency among vegetarians », The Journal of Nutrition, vol. 136, no 8,‎ , p. 2188–93 (PMID 16857839, DOI 10.1093/jn/136.8.2188)
  • Rowland, Wiseman, H, Sanders, TA et Adlercreutz, H, « Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora », Nutrition and Cancer, vol. 36, no 1,‎ , p. 27–32 (PMID 10798213, DOI 10.1207/S15327914NC3601_5)
  • Watanabe, Yamaguchi, M, Sobue, T et Takahashi, T, « Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako) », The Journal of Nutrition, vol. 128, no 10,‎ , p. 1710–5 (PMID 9772140, DOI 10.1093/jn/128.10.1710)
  • Arai, Uehara, M, Sato, Y et Kimira, M, « Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake », Journal of Epidemiology, vol. 10, no 2,‎ , p. 127–35 (PMID 10778038, DOI 10.2188/jea.10.127)
  • Akaza, Miyanaga, N, Takashima, N et Naito, S, « Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents », Japanese Journal of Clinical Oncology, vol. 34, no 2,‎ , p. 86–9 (PMID 15067102, DOI 10.1093/jjco/hyh015)
  • Song, Atkinson, C, Frankenfeld, CL et Jokela, T, « Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls », The Journal of Nutrition, vol. 136, no 5,‎ , p. 1347–51 (PMID 16614428, DOI 10.1093/jn/136.5.1347)
  • Patisaul et Jefferson, « The pros and cons of phytoestrogens. », Front Neuroendocrinol, vol. 31, no 4,‎ , p. 400–419 (PMID 20347861, PMCID 3074428, DOI 10.1016/j.yfrne.2010.03.003)
  • Teas et Hurley, TG, « Dietary seaweed modifies estrogen and phytoestrogen metabolism in healthy postmenopausal women », The Journal of Nutrition, vol. 139, no 9,‎ , p. 939–44 (PMID 19321575, DOI 10.3945/jn.108.100834)
  • « S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora », Am. J. Clin. Nutr., vol. 81, no 5,‎ , p. 1072–9 (PMID 15883431, DOI 10.1093/ajcn/81.5.1072)
  • Setchell et Clerici, « Equol: History, Chemistry, and Formation », The Journal of Nutrition, vol. 140, no 7,‎ , p. 1355S–1362S (PMID 20519412, PMCID 2884333, DOI 10.3945/jn.109.119776)
  • Lephart, « Protective effects of equol and their polyphenolic isomers against dermal aging: Microarray/protein evidence with clinical implications and unique delivery into human skin », Pharmaceutical Biology, vol. 51, no 11,‎ , p. 1393–1400 (ISSN 1388-0209, PMID 23862588, DOI 10.3109/13880209.2013.793720)
  • « Skin aging and oxidative stress: Equol's anti-aging effects via biochemical and molecular mechanisms », Ageing Research Reviews, vol. 31,‎ , p. 36–54 (PMID 27521253, DOI 10.1016/j.arr.2016.08.001)
  • Magnet, Urbanek, Gaisberger et Tomeva, « Topical equol preparation improves structural and molecular skin parameters », International Journal of Cosmetic Science, vol. 39, no 5,‎ , p. 535–542 (PMID 28574180, DOI 10.1111/ics.12408)

oxfordjournals.org

toxsci.oxfordjournals.org

  • « Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor {α} (ER{α}) and ERβ in human cells », Toxicol. Sci., vol. 80, no 1,‎ , p. 14–25 (PMID 15084758, DOI 10.1093/toxsci/kfh147, lire en ligne)

wiley.com

onlinelibrary.wiley.com

  • (en) Vivienne E. Reeve, Sitarina Widyarini, Diane Domanski et Elaine Chew, « Protection Against Photoaging in the Hairless Mouse by the Isoflavone Equol », Photochemistry and Photobiology, vol. 81, no 6,‎ , p. 1548–1553 (ISSN 0031-8655 et 1751-1097, DOI 10.1562/2005-07-26-RA-624, lire en ligne, consulté le )